Veldman RJ - Search Results

1

AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency.

Vaessen SF, Veldman RJ, Comijn EM, Snapper J, Sierts JA, van den Oever K, Beattie SG, Twisk J, Kuivenhoven JA. Vaessen SF, et al. Among authors: veldman rj. J Gene Med. 2009 Aug;11(8):697-707. doi: 10.1002/jgm.1344. J Gene Med. 2009. PMID: 19431216

2

Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.

Nierman MC, Prinsen BH, Rip J, Veldman RJ, Kuivenhoven JA, Kastelein JJ, de Sain-van der Velden MG, Stroes ES. Nierman MC, et al. Among authors: veldman rj. Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2410-5. doi: 10.1161/01.ATV.0000188506.79946.ce. Epub 2005 Sep 29. Arterioscler Thromb Vasc Biol. 2005. PMID: 16195478 Clinical Trial.

3

ABCA1-dependent but apoA-I-independent cholesterol efflux mediated by fatty acid-bile acid conjugates (FABACs).

Goldiner I, van der Velde AE, Vandenberghe KE, van Wijland MA, Halpern Z, Gilat T, Konikoff FM, Veldman RJ, Groen AK. Goldiner I, et al. Among authors: veldman rj. Biochem J. 2006 Jun 15;396(3):529-36. doi: 10.1042/BJ20051694. Biochem J. 2006. PMID: 16522192 Free PMC article.

4

Ceramide: second messenger or modulator of membrane structure and dynamics?

van Blitterswijk WJ, van der Luit AH, Veldman RJ, Verheij M, Borst J. van Blitterswijk WJ, et al. Among authors: veldman rj. Biochem J. 2003 Jan 15;369(Pt 2):199-211. doi: 10.1042/BJ20021528. Biochem J. 2003. PMID: 12408751 Free PMC article. Review.

5

Specificity of FNR-type regulators in Paracoccus denitrificans.

Veldman R, Reijnders WN, van Spanning RJ. Veldman R, et al. Biochem Soc Trans. 2006 Feb;34(Pt 1):94-6. doi: 10.1042/BST0340094. Biochem Soc Trans. 2006. PMID: 16417491

6

Metabolism and apoptotic properties of elevated ceramide in HT29rev cells.

Veldman RJ, Klappe K, Hoekstra D, Kok JW. Veldman RJ, et al. Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):563-9. doi: 10.1042/bj3310563. Biochem J. 1998. PMID: 9531498 Free PMC article.

7

Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.

van Lummel M, van Blitterswijk WJ, Vink SR, Veldman RJ, van der Valk MA, Schipper D, Dicheva BM, Eggermont AM, ten Hagen TL, Verheij M, Koning GA. van Lummel M, et al. Among authors: veldman rj. FASEB J. 2011 Jan;25(1):280-9. doi: 10.1096/fj.10-163709. Epub 2010 Sep 27. FASEB J. 2011. PMID: 20876209

8

Inhibition of P-glycoprotein activity and chemosensitization of multidrug-resistant ovarian carcinoma 2780AD cells by hexanoylglucosylceramide.

Veldman RJ, Sietsma H, Klappe K, Hoekstra D, Kok JW. Veldman RJ, et al. Biochem Biophys Res Commun. 1999 Dec 20;266(2):492-6. doi: 10.1006/bbrc.1999.1850. Biochem Biophys Res Commun. 1999. PMID: 10600530

9

Interferon-gamma-induced differentiation and apoptosis of HT29 cells: dissociation of (glucosyl)ceramide signaling.

Veldman RJ, Klappe K, Hoekstra D, Kok JW. Veldman RJ, et al. Biochem Biophys Res Commun. 1998 Jun 29;247(3):802-8. doi: 10.1006/bbrc.1998.8896. Biochem Biophys Res Commun. 1998. PMID: 9647774

10

A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling.

Veldman RJ, Maestre N, Aduib OM, Medin JA, Salvayre R, Levade T. Veldman RJ, et al. Biochem J. 2001 May 1;355(Pt 3):859-68. doi: 10.1042/bj3550859. Biochem J. 2001. PMID: 11311151 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page